Pharmacological Reviews xPharm- The Comprehensive Pharmacology Reference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/06/5804-760-772$7.00
Pharmacol Rev 58:760-772, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in Pharmacological Reviews
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Germain, P.
Right arrow Articles by Gronemeyer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Germain, P.
Right arrow Articles by Gronemeyer, H.

Article

International Union of Pharmacology. LXIII. Retinoid X Receptors

Pierre Germain, Pierre Chambon, Gregor Eichele, Ronald M. Evans, Mitchell A. Lazar, Mark Leid, Angel R. De Lera, Reuben Lotan, David J. Mangelsdorf and Hinrich Gronemeyer

Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale/Université Louis Pasteur, Illkirch, Communauté Urbaine de Strasbourg, France (P.G., P.C., H.G.); Max-Planck-Institute of Experimental Endocrinology, Hannover, Germany (G.E.); Howard Hughes Medical Institute, Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California (R.M.E.); Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and the Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania (M.A.L.); Program in Molecular and Cellular Biology, Oregon State University, Corvallis, Oregon (M.L.); Departamento de Quimica Organica, Facultade de Quimica, Universidade de Vigo, Lagoas Marcosende, Vigo, Galicia, Spain (A.R.d.L.); Department of Thoracic/Head and Neck Medical Oncology-Unit 432, The University of Texas MD Anderson Cancer Center, Houston, Texas (R.L.); and Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M.)

Abstract
Introduction
The RXRs
Ligands
Expression and Function of RXRs
Therapy and Diseases
Abstract

The physiological effects of retinoic acids (RAs) are mediated by members of two families of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs), which are encoded by three distinct human genes, RXR{alpha}, RXRbeta, and RXR{gamma}. RARs bind both all-trans- and 9-cis-RA, whereas only the 9-cis-RA stereoisomer binds to RXRs. As RXR/RAR heterodimers, these receptors control the transcription of RA target genes through binding to RA-response elements. This review is focused on the structure, mode of action, ligands, expression, and pharmacology of RXRs. Given their role as common partners to many other members of the nuclear receptor superfamily, these receptors have been the subject of intense scrutiny. Moreover, and despite numerous studies since their initial discovery, RXRs remain enigmatic nuclear receptors, and there is still no consensus regarding their role. Indeed, multiple questions about the actual biological role of RXRs and the existence of an endogenous ligand have still to be answered.


Address correspondence to: Dr. Pierre Germain, Department of Cell Biology and Signal Transduction, Institut de Genetique et de Biologie Moleculaire et Cellulaire, 1 rue Laurent Fries, BP 10142, 67404 Illkirch Cedex, France. E-mail: germain{at}titus.u-strasbg.fr


Related articles in Pharmacological Reviews:

International Union of Pharmacology. LX. Retinoic Acid Receptors
Pierre Germain, Pierre Chambon, Gregor Eichele, Ronald M. Evans, Mitchell A. Lazar, Mark Leid, Angel R. De Lera, Reuben Lotan, David J. Mangelsdorf, and Hinrich Gronemeyer
Pharmacological Reviews 2006 58: 712-725. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
Y. Hai, W. Cao, G. Liu, S.-P. Hong, S. A. Elela, R. Klinck, J. Chu, and J. Xie
A G-tract element in apoptotic agents-induced alternative splicing
Nucleic Acids Res., June 1, 2008; 36(10): 3320 - 3331.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A. De Gottardi, A. Hadengue, and J.-M. Dumonceau
Retinoids, bile acids and PPARs in Barrett's oesophagus
Gut, January 1, 2008; 57(1): 137 - 137.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. F. Gillespie and L. J. Gudas
Retinoic Acid Receptor Isotype Specificity in F9 Teratocarcinoma Stem Cells Results from the Differential Recruitment of Coregulators to Retinoic Acid Response Elements
J. Biol. Chem., November 16, 2007; 282(46): 33421 - 33434.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Das, M. Schapira, M. Tomic-Canic, R. Goyanka, T. Cardozo, and H. H. Samuels
Farnesyl Pyrophosphate Is a Novel Transcriptional Activator for a Subset of Nuclear Hormone Receptors
Mol. Endocrinol., November 1, 2007; 21(11): 2672 - 2686.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Nahoum, E. Perez, P. Germain, F. Rodriguez-Barrios, F. Manzo, S. Kammerer, G. Lemaire, O. Hirsch, C. A. Royer, H. Gronemeyer, et al.
Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function
PNAS, October 30, 2007; 104(44): 17323 - 17328.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. R. Howe
Rexinoids and Breast Cancer Prevention
Clin. Cancer Res., October 15, 2007; 13(20): 5983 - 5987.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. De los Santos, A. Zambrano, A. Sanchez-Pacheco, and A. Aranda
Histone Deacetylase Inhibitors Regulate Retinoic Acid Receptor {beta} Expression in Neuroblastoma Cells by Both Transcriptional and Posttranscriptional Mechanisms
Mol. Endocrinol., October 1, 2007; 21(10): 2416 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. L. Horn, K. E. O. Torres, J. M. Naylor, M. J. Cwik, C. J. Detrisac, I. M. Kapetanovic, R. A. Lubet, J. A. Crowell, and D. L. McCormick
Subchronic Toxicity and Toxicogenomic Evaluation of Tamoxifen Citrate + Bexarotene in Female Rats
Toxicol. Sci., October 1, 2007; 99(2): 612 - 627.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Schupp, J. C. Curtin, R. J. Kim, A. N. Billin, and M. A. Lazar
A Widely Used Retinoic Acid Receptor Antagonist Induces Peroxisome Proliferator-Activated Receptor-{gamma} Activity
Mol. Pharmacol., May 1, 2007; 71(5): 1251 - 1257.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics